Keep in mind the disappointing history of this stock
not only that-- this isn't the best in class drug out there. Big pharma isn't going to partner up with zalicus for this drug until many quarters after FDA marketing approval. Too early to be a die hard long. They need to start showing 80% gross margin before even thinking that they will get bought out.
Next news will just be a pump, so they could stay away from delisting, and start diluting their shares for the PHASE II clinical process. That thing isn't free, and without any financial support from other big pharma or government, the support has to come from shareholders.
Now Merlin, you tried to take Goose's place with Maverick and fail like a chubbster dieting in a cheesecake factory and all you could say is "you're doing what?". Give it a break, your pointless "insightfull" post are as bad your acting in Top Gun.